<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ongtanasup T</submitter><funding>Walailak University</funding><funding>New Strategic Research (P2P) project, Walailak University, Thailand</funding><funding>Walailak University, Thailand</funding><funding>FCT/MEC (PIDDAC)</funding><pagination>1835</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9318486</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(14)</volume><pubmed_abstract>PCSK9 is a promising target for developing novel cholesterol-lowering drugs. We developed a recipe that combined molecular docking, GC-MS/MS, and real-time PCR to identify potential PCSK9 inhibitors for herb ratio determination. Three herbs, &lt;i>Carthamus tinctorius&lt;/i>, &lt;i>Coscinium fenestratum&lt;/i>, and &lt;i>Zingiber officinale,&lt;/i> were used in this study. This work aimed to evaluate cholesterol-lowering through a PCSK9 inhibitory mechanism of these three herbs for defining a suitable ratio. Chemical constituents were identified using GC-MS/MS. The PCSK9 inhibitory potential of the compounds was determined using molecular docking, real-time PCR, and Oil red O staining. It has been shown that most of the active compounds of &lt;i>C. fenestratum&lt;/i> and &lt;i>Z. officinale&lt;/i> inhibit PCSK9 when ex</pubmed_abstract><journal>Plants (Basel, Switzerland)</journal><pubmed_title>The Cholesterol-Modulating Effect of the New Herbal Medicinal Recipe from Yellow Vine (&lt;i>Coscinium fenestratum&lt;/i> (Goetgh.)), Ginger (&lt;i>Zingiber officinale&lt;/i> Roscoe.), and Safflower (&lt;i>Carthamus tinctorius&lt;/i> L.) on Suppressing PCSK9 Expression to Upregulate LDLR Expression in HepG2 Cells.</pubmed_title><pmcid>PMC9318486</pmcid><funding_grant_id>UIDP/50011/2020</funding_grant_id><funding_grant_id>LA/P/0006/2020</funding_grant_id><funding_grant_id>WU-IRG-65-013</funding_grant_id><funding_grant_id>UIDB/50011/2020</funding_grant_id><pubmed_authors>Nissapatorn V</pubmed_authors><pubmed_authors>Jampa O</pubmed_authors><pubmed_authors>Pereira ML</pubmed_authors><pubmed_authors>Wilairatana P</pubmed_authors><pubmed_authors>Wanmasae S</pubmed_authors><pubmed_authors>Eawsakul K</pubmed_authors><pubmed_authors>Prommee N</pubmed_authors><pubmed_authors>Limcharoen T</pubmed_authors><pubmed_authors>Paul AK</pubmed_authors><pubmed_authors>Ongtanasup T</pubmed_authors><pubmed_authors>Nasongkla N</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Cholesterol-Modulating Effect of the New Herbal Medicinal Recipe from Yellow Vine (&lt;i>Coscinium fenestratum&lt;/i> (Goetgh.)), Ginger (&lt;i>Zingiber officinale&lt;/i> Roscoe.), and Safflower (&lt;i>Carthamus tinctorius&lt;/i> L.) on Suppressing PCSK9 Expression to Upregulate LDLR Expression in HepG2 Cells.</name><description>PCSK9 is a promising target for developing novel cholesterol-lowering drugs. We developed a recipe that combined molecular docking, GC-MS/MS, and real-time PCR to identify potential PCSK9 inhibitors for herb ratio determination. Three herbs, &lt;i>Carthamus tinctorius&lt;/i>, &lt;i>Coscinium fenestratum&lt;/i>, and &lt;i>Zingiber officinale,&lt;/i> were used in this study. This work aimed to evaluate cholesterol-lowering through a PCSK9 inhibitory mechanism of these three herbs for defining a suitable ratio. Chemical constituents were identified using GC-MS/MS. The PCSK9 inhibitory potential of the compounds was determined using molecular docking, real-time PCR, and Oil red O staining. It has been shown that most of the active compounds of &lt;i>C. fenestratum&lt;/i> and &lt;i>Z. officinale&lt;/i> inhibit PCSK9 when ex</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2026-05-10T03:19:56.021Z</modification><creation>2022-08-06T14:41:41.478Z</creation></dates><accession>S-EPMC9318486</accession><cross_references><pubmed>35890469</pubmed><doi>10.3390/plants11141835</doi></cross_references></HashMap>